Abstract:BackgroundCarotid intima media thickness (CIMT) is a non invasive marker of subclinical atherosclerosis. Hyperglycemia, oxidatively modified atherogenic lipoproteins and advanced glycation end products are linked to increased oxidative stress in diabetes. We aimed to find out the relation between carotid intima media thickness in type 1 diabetic children and adolescents and plasma nitric oxide and total antioxidant capacity levels as markers of oxidative stress.MethodsThis study included 50 children and adoles… Show more
“…In these studies, the duration of the disease was shorter than that in our study, which might explain our findings. Furthermore, we found no association between CIMT and glycemic control measured by HbA1c, as reported in other studies (19,20). Our results are similar to those of another study in a cohort of 603 patients with type 1 DM followed up for 10 years, which found that a better glycemic control was unable to predict the occurrence of coronary artery disease (CAD), in contrast to insulin resistance measured by eGDR, which emerged as a predictor of CAD endpoints (27).…”
Section: Discussionsupporting
confidence: 69%
“…A study in 150 patients with longstanding type 1 DM has found a lower prevalence of subclinical atherosclerosis (18). In contrast, other studies have reported increased CIMT in children and adolescents with type 1 DM, demonstrating that the atherosclerotic process may start at a young age in these patients (19,20). Our results provide further evidence of the importance of screening for subclinical CVD in women with type 1 DM.…”
Section: Resultssupporting
confidence: 52%
“…This finding contrasts with previous studies that have demonstrated that CIMT increases with the duration of type 1 DM (19,20,36). In these studies, the duration of the disease was shorter than that in our study, which might explain our findings.…”
Section: Discussioncontrasting
confidence: 56%
“…There are controversies in the literature regarding the association of age and CIMT, in which positive (20,36) and negative (19) results have been reported, but none of these studies have evaluated the presence of carotid plaques.…”
Objective: This study aimed to evaluate the occurrence and clinical predictors of subclinical atherosclerosis in asymptomatic, young adult women with type 1 DM. Subjects and methods: The study included 45 women with type 1 diabetes mellitus (DM) (aged 36 ± 9 years) who underwent carotid Doppler ultrasound evaluation to determine the carotid artery intima-media thickness (CIMT) and to assess the occurrence of carotid artery plaques. Insulin sensitivity was assessed by estimated glucose disposal rate (eGDR), and metabolic syndrome (MS) was defined by the World Health Organization criteria. Results: The cohort had a mean age of 36 ± 9 years, diabetes duration of 18.1 ± 9.5 years, and body mass index (BMI) of 24.6 ± 2.4 kg/m 2 . MS was present in 44.4% of the participants. The CIMT was 0.25 ± 0.28 mm, and the prevalence of carotid artery plaques was 13%. CIMT correlated positively with hypertension (p = 0.04) and waist-to-hip ratio (r = 0.37, p = 0.012). The presence of carotid artery plaques correlated positively with age (p = 0.018) and hypertension (p = 0.017). eGDR correlated negatively with CIMT (r = -0.39, p = 0.009) and carotid plaques (p = 0.04). Albuminuria showed a correlation trend with CIMT (p = 0.06). Patients with carotid artery plaques were older, had a higher prevalence of hypertension, and lower eGDR. No correlation was found between CIMT and carotid plaques with diabetes duration, MS, BMI, cholesterol profile, glycated hemoglobin, high-sensitivity C-reactive protein, or fibrinogen. Conclusion: Insulin resistance, central obesity, hypertension, and older age were predictors of subclinical atherosclerosis in asymptomatic, young adult women with type 1 DM. Arch Endocrinol Metab. 2017;61(2):115-21.
“…In these studies, the duration of the disease was shorter than that in our study, which might explain our findings. Furthermore, we found no association between CIMT and glycemic control measured by HbA1c, as reported in other studies (19,20). Our results are similar to those of another study in a cohort of 603 patients with type 1 DM followed up for 10 years, which found that a better glycemic control was unable to predict the occurrence of coronary artery disease (CAD), in contrast to insulin resistance measured by eGDR, which emerged as a predictor of CAD endpoints (27).…”
Section: Discussionsupporting
confidence: 69%
“…A study in 150 patients with longstanding type 1 DM has found a lower prevalence of subclinical atherosclerosis (18). In contrast, other studies have reported increased CIMT in children and adolescents with type 1 DM, demonstrating that the atherosclerotic process may start at a young age in these patients (19,20). Our results provide further evidence of the importance of screening for subclinical CVD in women with type 1 DM.…”
Section: Resultssupporting
confidence: 52%
“…This finding contrasts with previous studies that have demonstrated that CIMT increases with the duration of type 1 DM (19,20,36). In these studies, the duration of the disease was shorter than that in our study, which might explain our findings.…”
Section: Discussioncontrasting
confidence: 56%
“…There are controversies in the literature regarding the association of age and CIMT, in which positive (20,36) and negative (19) results have been reported, but none of these studies have evaluated the presence of carotid plaques.…”
Objective: This study aimed to evaluate the occurrence and clinical predictors of subclinical atherosclerosis in asymptomatic, young adult women with type 1 DM. Subjects and methods: The study included 45 women with type 1 diabetes mellitus (DM) (aged 36 ± 9 years) who underwent carotid Doppler ultrasound evaluation to determine the carotid artery intima-media thickness (CIMT) and to assess the occurrence of carotid artery plaques. Insulin sensitivity was assessed by estimated glucose disposal rate (eGDR), and metabolic syndrome (MS) was defined by the World Health Organization criteria. Results: The cohort had a mean age of 36 ± 9 years, diabetes duration of 18.1 ± 9.5 years, and body mass index (BMI) of 24.6 ± 2.4 kg/m 2 . MS was present in 44.4% of the participants. The CIMT was 0.25 ± 0.28 mm, and the prevalence of carotid artery plaques was 13%. CIMT correlated positively with hypertension (p = 0.04) and waist-to-hip ratio (r = 0.37, p = 0.012). The presence of carotid artery plaques correlated positively with age (p = 0.018) and hypertension (p = 0.017). eGDR correlated negatively with CIMT (r = -0.39, p = 0.009) and carotid plaques (p = 0.04). Albuminuria showed a correlation trend with CIMT (p = 0.06). Patients with carotid artery plaques were older, had a higher prevalence of hypertension, and lower eGDR. No correlation was found between CIMT and carotid plaques with diabetes duration, MS, BMI, cholesterol profile, glycated hemoglobin, high-sensitivity C-reactive protein, or fibrinogen. Conclusion: Insulin resistance, central obesity, hypertension, and older age were predictors of subclinical atherosclerosis in asymptomatic, young adult women with type 1 DM. Arch Endocrinol Metab. 2017;61(2):115-21.
“…Our data revealed that the total antioxidant activity (ORAC) decreased in the plasma of children with diabetes in favor of an oxidative stress in such patients. These results are in agreement with previous studies (El Samahy et al, 2013;Varvarovská et al, 2003).…”
Children's diabetes is represented by the Type 1 diabetes mellitus (T1DM). In T1DM, the persistence of hyperglycemia has been reported to cause increased production of oxygen free radicals through glucose autooxidation and nonenzymatic glycation. The aim of this study was to evaluate markers of oxidant/antioxidant status in diabetic children of Western Algeria. This study included 40 children with T1DM with mean age of 7.5 ± 1.7 years and 40 healthy age and sex matched controls. They were subjected to assessment of indicative parameters of lipoperoxidation, protein oxidation, changes in the status of antioxidant defense systems, plasma oxygen radical absorbance capacity (ORAC), glycated hemoglobin (HbA1c), total cholesterol and triglycerides. Malondialdehyde (MDA) and carbonyl proteins levels in plasma were significantly higher (4.03 ± 0.39 versus 2.53 ± 0.4 µmol/L, 5.03 ± 0.57 versus 3 ± 0.38 nmol/mg protein, respectively; P < 0.001) and a significant reduction in plasma total antioxidant capacity and vitamin C was observed in diabetic children than the controls (1.55 ± 0.28 versus 2.5 ± 0.23 AU, 37.58 ± 5.76 versus 48.8 ± 4.47 µmol/L, respectively; P < 0.001). Erythrocyte superoxide dismutase (SOD) and catalase (CAT) activities were significantly higher (520 ± 40.42 versus 392.7 ± 42.66 U/g hemoglobin, 71.08 ± 5.18 versus 56.6 ± 2.84 U/g hemoglobin, respectively; P < 0.001), whereas erythrocyte glutathione reductase (GSH) reduced significantly (34.98 ± 2.34 versus 42.68 ± 3.03 U/g hemoglobin, respectively; P < 0.001) in diabetic children than the control subject. The present finding suggested that young diabetic patients were susceptible to oxidative stress. Appropriate support for enhancing antioxidant supply in these patients may help prevent complications due to oxidative injury.
Maturity-onset diabetes of the young (MODY) is an unusual form of diabetes with specific features that distinguish it from type 1 and type 2 diabetes. There are 14 known subtypes of MODY, and mutations in three genes (HNF1A, HNF4A, GCK) account for about 95% of all MODY cases. Diagnosis usually occurs before the age of 25 years, although less frequent forms may occur more often-but not necessarilylater in life. The molecular diagnosis may tailor the choice of the most appropriate treatment, with the aim to optimize blood glucose control, reduce the risk of hypoglycemic events and long-term complications, and enable proper genetic counseling. Treatment is usually unnecessary for patients with mutations in the GCK gene, while oral hypoglycemic agents (generally sulphonylureas) are recommended for patients with mutations in the HNF4A and HNF1A genes. More recent data show that other glucose-lowering agents can be effective in the latter patients, and additional and alternative therapies have been proposed. Proper management guidelines during pregnancy have been developed for carriers of GCK gene mutations, but such guidelines are still a subject of debate in other cases, although some recommendations are available. The other subtypes of MODY are even more rare, and very little data are available in the literature. In this review we summarize the most pertinent findings and recommendations on the treatment of patients with the different subtypes of MODY. Our aim is to provide the reader with an easy-to-read update that can be used to drive the clinician's therapeutical approach to these patients after the molecular diagnosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.